Genes encoding for several receptor tyrosine kinases were mutated in a significant minority of CDX2-suppressed colon cancers, while the prevalence of such mutations was lower in most of these genes in the group with non-CDX2-suppressed colon cancers (Figure 12). This evidence concerns the gene CDX2 and malignant colon neoplasm.